SUMMARY After a 4-minute i.v. dipyridamole infusion, 0.14 mg/kg/min, serial thallium-201 scans were obtained in 60 patients undergoing cardiac catheterization. Forty patients had significant (> 50% stenosis) coronary artery disease (CAD), and 20 patients had normal coronary arteries or trivial lesions. The images were graded qualitatively for thallium activity by three observers. Sensitivity was 93% (37 of 40) and specificity was 80% (16 of 20). The sensitivity and specificity of the thallium-201 study were not affected by the extent of CAD, the presence of Q waves, or propranolol therapy. Twenty-seven of 37 patients who had initial defects (73%) had complete thallium redistribution of one or more defects. Patient-by-patient analysis using a regression model of all patients showed that the fate of a segmental thallium defect predicted abnormal wall motion by angiography better than ECG Q waves. The presence of propranolol therapy or collaterals did not significantly affect the thallium redistribution results.
of changes in thallium-201 distribution over time after dipyridamole infusion. We also evaluated the accuracy of serial dipyridamole thallium-201 images in detecting CAD and assessing myocardial viability in terms of regional wall motion. Finally, we investigated the effects of propranolol and collaterals on the scintigraphic observations.
Methods Patients
Sixty consecutive patients with chest pain syndromes referred for coronary angiography were studied. Each patient gave written, informed consent. No patient had associated heart disease. Coronary angiography and scintigraphy were performed within 48 hours of each other in all but four patients. The longest time between studies was 14 days. The patients were divided into two groups: 20 patients who had trivial or no coronary artery lesions and normal left ventriculograms and 40 patients who had significant CAD.
Dipyridamole Infusion and Thallium-201 Imaging
The imaging protocol ( fig. 1 ) is a modification of the technique described by Albro et al. ' 3 Each patient was placed supine on a tilt table. A 20-gauge plastic cannula was placed in a large antecubital vein, as infusing dipyridamole into a small vein is painful.
Twelve-lead ECGs and blood pressure measurements were obtained at baseline and at 1-minute intervals during the first 15 minutes of the study. The ECG was continuously monitored on an oscilloscope. While the patient was supine, i.v. dipyridamole (Boehringer-Ingelheim) was infused at a rate of 0.14 mg/kg/min for 4 minutes. After the infusion, the patient was tilted upright to 700, and 3 minutes later 1.5-2.0 mCi of i.v. thallium-201 (New England Nuclear) were injected. The patient was returned to the supine position 1 Table 3 presents the occurrence of adverse effects of dipyridamole among all patients and in the CAD and normal groups. The normal group had a higher incidence of transient headaches (independent of propranolol therapy) than the CAD patients (35% vs 13%), but all other side effects were comparably distributed between the two groups. Symptoms were noted in 43% of the studies, and in five patients (19% of those with symptoms) these were severe enough to prompt i.v. administration of aminophylline to reverse the action of dipyridamole. Aminophylline was given to one normal patient for nausea, to three CAD patients for angina, and to one CAD patient to reverse hypotension (80/ 60 mm Hg) that persisted after the patient was returned to the supine position. In these five patients, the onset of symptoms was near the end of or after the dipyridamole infusion so that the thallium-201 could be injected and circulate for 1 minute before the dipyridamole effect was reversed.
Eight CAD patients had angina during the protocol; five had three-vessel, two had two-vessel and one had one-vessel CAD. The extent of CAD differed significantly from that in the 32 patients who did not have angina (seven had three-vessel, 10 two-vessel and 15 one-vessel disease; p < 0.01). Five of the eight CAD patients who had angina had ST-segment depression on the ECG. The three CAD patients who were given aminophylline had ST-depression and three-vessel disease; and two of them had angina at rest, which suggests that patients with unstable angina may experience more severe symptoms. The heart rate, blood pressure and double product in patients who had angina were not significantly different from those in patients who did not have angina. Qualitative interpretation of thallium-201 images immediately after dipyridamole demonstrated 41 studies with one or more segmental abnormalities: 37 of 40 (93%) in the CAD group and four of 20 (20%) in the normal group (i.e., sensitivity 93% and specificity 80%). Two of the patients with a false-negative result had one-vessel disease and one patient had two-vessel disease. Only the patient with two-vessel disease had coronary collaterals and hypokinetic wall motion; the two other patients had normal wall motion. Three of the four patients with a false-positive scan were female, and breast attenuation may have caused the anteroapical segment abnormality noted in two of these studies. A 20% myocardial bridge of the left anterior descending coronary artery in the male patient with a false-positive result may have contributed to the anterolateral and apical segmental abnormalities. Two of the four patients who had false-positive results were taking propranolol.
The extent of CAD, ECG Q waves, collaterals, and propranolol therapy had no significant effect on sensitivity. All 16 patients (100%) who had Q waves and 21 of 24 patients (88%) without ECG evidence of infarction had abnormal thallium scans (NS). Figure 4 shows serial images from three patients who had thallium-201 redistribution and different wall motion findings. Of the 41 patients with initially abnormal scans, 30 (73%) had complete redistribution in at least one segment, seven (17%) had no redistribution (persistent defects), and four (10%) had partial redistribution. These data were evaluated patient by patient using a segmental approach to assess the overall significance of the thallium-201 redistribution. In each patient, the results of serial thallium-201 imaging as well as the presence or absence of ECG Q waves, collaterals, and propranolol therapy were compared with left ventricular wall motion using a stepwise, nonlinear logistic regression, as described above. The dependent variable was wall motion (asynergy), and the initial step in the computer model treats all the predicting variables independently. Although a significant chi-square value was noted for each variable, the delayed thallium-201 imaging score yielded a markedly higher value than any other. The chi-square value for the imaging score was 27.2, compared with 11.7 for collaterals, 7.0 for ECG Q waves and 5.4 for propranolol. The next step in the computer analysis included the thallium-201 imaging score into the model, and none of the other variables significantly improved the prediction of abnormal wall motion. In addition, an analysis for an interaction between propranolol and the thallium-201 score failed to demonstrate any significant effect. Therefore, the regression equation for the prediction (p) of asynergy in any patient from the delayed thallium-201 imaging score is as follows: Logit (p (asynergic wall motion)) = -1.9 + 0.36 (delayed thallium-201 score). This model demonstrated a sensitivity of 84% and a specificity of 82% using a cutoff value of 0.32 for asynergic wall motion in the population of 60 patients from which the parameters were estimated. The predicted probability of asynergy was 13% for a delayed thallium-201 score of 0 and was 23%, 38%, 56%, 72% and 84% for scores of 2, 4, 6, 8 and 10, respectively. An imaging score greater than 10 had a predicted probability of more than 90%.
Analysis of Delayed Thallium-201 Distribution
No significant distribution of collaterals was noted in CAD patients in regard to the extent of thallium-201 redistribution. Of 37 CAD patients with abnormal segments by thallium-201 scanning, 27 had complete redistribution, of whom 18 (67%) had collaterals. Seven of the remaining 10 patients (70%) who did not have complete thallium-201 redistribution had collateral vessels. Figure 5 shows the relationship between asynergic or normal regional wall motion and the fate of thallium-201 redistribution on serial images for 537 segments in 60 patients. There was a significant (p < 0.0001) Pearson chi-square relationship, and the correlation coefficient (r = 0.54) between the scintigraphic and angiographic observations was also significant (p < 0.01). Eighty-five percent of the normal thal- In this study, we showed that heart rate and double product increased and blood pressure decreased during the dipyridamole thallium-201 protocol. Other investigators have reported similar findings.'2 13 We also showed that propranolol significantly affected the heart rate response. Although Osbakken et al.2 suggested that propranolol might reduce the sensitivity and specificity of exercise thallium-201 scintigraphy, we found no such interaction with dipyridamole thallium-201 imaging. McLaughlin et al. 26 suggested that the heart rate response appears to affect the accuracy of the exercise thallium-201 study, but it appears to have no such impact on the dipyridamole study.
In contrast to exercise studies, which typically show a large increase in calculated double product, dipyridamole placed a much milder stress on the heart, which supports previous clinical observations of dipyridamole administration in catheterization studies.22 7 Nevertheless, 20% of the CAD patients had angina. This appeared to be related to the presence of multivessel CAD, as five of the 12 patients (42%) with threevessel disease had angina, compared with only three of 28 patients (1 1%) with one-and two-vessel disease (p < 0.01). Three patients with three-vessel disease also why sensitivity was slightly higher in the present study than in previous studies that used qualitative consensus interpretation. 13-16, 38, 39 The influence of the severity of CAD on dipyridamole thallium-201 imaging has not been reviewed. Sochor et al.39 reported preliminary data that showed a sensitivity of 79% for this technique in patients without prior infarction, whereas we found a sensitivity of 88%. The effect of the extent of coronary disease and previous infarction on our imaging results is similar to that reported for exercise thallium-201 scintigraphy. 5' 6, 40 Alterations in sensitivity and specificity of thallium-201 exercise scans have been attributed to the presence of collateral vessels,4' propranolol therapy,25 and the adequacy of exercise.26 These factors do not affect the dipyridamole thallium-201 data. Although propranolol blunted the heart rate response during the dipyridamole infusion, there was no apparent effect on the induced disparity in regional myocardial blood flow. Therefore, dipyridamole thallium-201 imaging is not affected by 83 blockade and may provide an alternative to exercise thallium-201 studies in patients receiving propranolol therapy.
Thallium-201 Redistribution After Dipyridamole
Thallium-201 redistribution after a vasodilator infusion has been described in a canine model of coronary stenosis. 42 The results of the present study suggest that the factors affecting whether an initial defect fills in after dipyridamole are similar to those affecting exercise studies. The excellent correlation between regional dipyridamole thallium-201 redistribution results and regional wall motion is consistent with observations in exercise myocardial perfusion studies,>'°22 as is the significant superiority of the scan data to the ECG data in predicting akinesis or dyskinesis.9 '°O ur qualitative interpretation of serial thallium-201 images after dipyridamole yielded a sensitivity of 84% and a specificity of 82% for detecting asynergy. Thus, a significant probability of abnormal wall motion can be determined by assessing thallium redistribution in initial defects, and normal tracer uptake probably predicts the absence of asynergy. In addition, the number of patients who had complete thallium-201 redistribution was not affected by the presence of collateral vessels. Neither ECG Q waves nor propranolol therapy made a statistically significant contribution beyond that made by thallium-201 alone in predicting abnormal regional contraction. Therefore, considering only the noninvasive variables used in this study, thallium-201 imaging appears to be the best method for evaluating regional myocardial viability.
Although a segment-by-segment analysis showed that the overall relationship between the scintigraphic and angiographic findings was significant, approximately one-third of the akinetic or dyskinetic segments showed normal thallium-201 uptake or complete redistribution of an initial defect. This discordance between thallium-201 and wall motion results has been observed by others, 8' 22, 23 and demonstrates the limita-VOL 66, No 3, SEPTEMBER 1982 tions in comparing segmented thallium-201 distribution with regional motion as an indicator of myocardial viability. Some reservations about the correlation of akinesis with myocardial viability have been presented by other investigators, who compared postmortem results43 or epicardial scars noted at bypass surgery10 with angiographic observations. Berger et al.23 reported that thalliunm redistribution occurred in akinetic segments that had improved wall motion after coronary artery bypass surgery and that thallium-201 uptake improved postoperatively in segments that had persistent defects initially. Spatial resolution and overlap of normal myocardium also affect the ability of thallium-201 imaging to demonstrate a defect. Although there are inherent problems in determining the presence of viable myocardium in a given segment, dipyridamole thallium-201 imaging can be expected to achieve results similar to those in previous scintigraphic studies 8-10, 22, 23 In conclusion, serial thallium-201 myocardial imaging after dipyridamole is a highly sensitive and specific test for CAD that does not require exercise or patient effort and is independent of the presence of the collaterals or propranolol therapy. However, as with exercise studies, the use of delayed imaging to evaluate thallium-20 1 redistribution allows prediction of myocardial viability with greater accuracy than ECG Q waves. Serial thallium-201 scans after dipyridamole can be interpreted in a manner similar to maximal exercise scans and may prove to be a useful alternative.
